首页> 外文OA文献 >Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis
【2h】

Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis

机译:人参皂甙诱导人原代破骨细胞凋亡的研究 药用植物余甘子的提取物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Osteoclasts (OCs) are involved in rheumatoid arthritis and in several pathologies associated withbone loss. Recent results support the concept that some medicinal plants and derived natural products are ofgreat interest for developing therapeutic strategies against bone disorders, including rheumatoid arthritis andosteoporosis. In this study we determined whether extracts of Emblica officinalis fruits display activity of possibleinterest for the treatment of rheumatoid arthritis and osteoporosis by activating programmed cell death of humanprimary osteoclasts.Methods: The effects of extracts from Emblica officinalis on differentiation and survival of human primary OCscultures obtained from peripheral blood were determined by tartrate-acid resistant acid phosphatase (TRAP)-positivity and colorimetric MTT assay. The effects of Emblica officinalis extracts on induction of OCs apoptosiswere studied using TUNEL and immunocytochemical analysis of FAS receptor expression. Finally, in vitro effectsof Emblica officinalis extracts on NF-kB transcription factor activity were determined by gel shift experiments.Results: Extracts of Emblica officinalis were able to induce programmed cell death of mature OCs, withoutaltering, at the concentrations employed in our study, the process of osteoclastogenesis. Emblica officinalisincreased the expression levels of Fas, a critical member of the apoptotic pathway. Gel shift experimentsdemonstrated that Emblica officinalis extracts act by interfering with NF-kB activity, a transcription factor involvedin osteoclast biology. The data obtained demonstrate that Emblica officinalis extracts selectively compete with thebinding of transcription factor NF-kB to its specific target DNA sequences. This effect might explain the observedeffects of Emblica officinalis on the expression levels of interleukin-6, a NF-kB specific target gene.Conclusion: Induction of apoptosis of osteoclasts could be an important strategy both in interfering withrheumatoid arthritis complications of the bone skeleton leading to joint destruction, and preventing and reducingosteoporosis. Accordingly, we suggest the application of Emblica officinalis extracts as an alternative tool fortherapy applied to bone diseases.
机译:背景:破骨细胞(OCs)与类风湿性关节炎有关,并与骨丢失有关。最近的结果支持这样的概念,即一些药用植物和衍生的天然产物对于开发针对包括风湿性关节炎和骨质疏松症在内的骨疾病的治疗策略非常感兴趣。在这项研究中,我们确定了余甘子果实的提取物是否通过激活人原代破骨细胞的程序性细胞死亡来治疗类风湿性关节炎和骨质疏松症具有潜在的兴趣。酒石酸耐酸性磷酸酶(TRAP)阳性和比色MTT法测定外周血中的血红素。用TUNEL和FAS受体表达的免疫细胞化学分析研究了余甘子提取物对OCs凋亡的诱导作用。最后,通过凝胶电泳实验确定了余甘子提取物对NF-kB转录因子活性的体外作用。结果:余甘子提取物能够在不改变实验条件下诱导成熟OC的程序性细胞死亡。破骨细胞形成的过程。余甘子增加了凋亡途径的关键成员Fas的表达水平。凝胶移位实验证明,余甘子提取物通过干扰破骨细胞生物学相关的转录因子NF-kB的活性来发挥作用。获得的数据表明,余甘子提取物选择性地与转录因子NF-kB与其特异性靶DNA序列的结合竞争。这种作用可能解释了Emblica officinalis对NF-kB特异性靶基因白细胞介素6表达水平的影响。结论:破骨细胞凋亡的诱导可能是干预骨关节炎类风湿性关节炎并发症的重要策略。关节破坏,预防和减少骨质疏松症。因此,我们建议将Emblica officinalis提取物用作治疗骨病的替代工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号